Amphastar Pharmaceuticals... (AMPH)
NASDAQ: AMPH
· Real-Time Price · USD
23.14
-0.72 (-3.02%)
At close: Oct 15, 2025, 3:59 PM
23.00
-0.61%
After-hours: Oct 15, 2025, 05:59 PM EDT
Amphastar Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
Revenue | 712.81M | 644.39M | 498.99M | 437.77M |
Cost of Revenue | 338.96M | 293.27M | 250.13M | 238.03M |
Gross Profit | 373.86M | 351.12M | 248.86M | 199.74M |
Operating Income | 205.42M | 196.99M | 107.5M | 69.89M |
Interest Income | 10.61M | 5.46M | 1.32M | 601K |
Pretax Income | 189.76M | 169.38M | 114.86M | 84.14M |
Net Income | 159.52M | 137.54M | 91.39M | 62.12M |
Selling & General & Admin | 94.52M | 80.39M | 66.59M | 68.92M |
Research & Development | 73.91M | 73.74M | 74.77M | 60.93M |
Other Expenses | n/a | n/a | n/a | n/a |
Operating Expenses | 168.44M | 154.13M | 141.36M | 129.85M |
Interest Expense | 30.34M | 27.16M | 1.85M | 885K |
Selling & Marketing Expenses | 37.8M | 28.85M | 21.53M | 17.49M |
Cost & Expenses | 507.39M | 447.41M | 391.49M | 367.88M |
Income Tax Expense | 29.67M | 31.83M | 23.48M | 20.63M |
Shares Outstanding (Basic) | 48.43M | 48.27M | 48.55M | 47.78M |
Shares Outstanding (Diluted) | 52.06M | 53M | 52.43M | 49.78M |
EPS (Basic) | 3.29 | 2.85 | 1.88 | 1.30 |
EPS (Diluted) | 3.06 | 2.60 | 1.74 | 1.25 |
EBITDA | 277.31M | 240.29M | 146.16M | 111.78M |
EBIT | 220.11M | 198.52M | 117.89M | 85.02M |
Depreciation & Amortization | 57.2M | 41.78M | 28.27M | 26.75M |
Source: Financial Modeling Prep. Financial Sources.